I now have a complete picture. The textbooks do not document specific pregnancy safety data for racecadotril — a clinically important finding in itself. Here is the synthesis:
Racecadotril in Pregnancy — What the Evidence Says
What Is Racecadotril?
Racecadotril (acetorphan) is a prodrug converted in the body to thiorphan, a peripheral enkephalinase (neutral endopeptidase) inhibitor. By blocking the breakdown of endogenous enkephalins in the gut, it potentiates their antisecretory effect on opioid receptors in the GI tract — reducing intestinal hypersecretion without affecting motility. This is its key advantage over loperamide: it does not cause paralytic ileus or constipation.
- Dose (adults): 100 mg orally every 8 hours, up to 7 days
- Dose (children): 1.5 mg/kg every 8 hours with ORS
- Available in many countries; not available in the US
Safety in Pregnancy — The Critical Gap
None of the authoritative textbooks in the library (Yamada's Gastroenterology, Goodman & Gilman's, Goldman-Cecil Medicine) include racecadotril in their pregnancy safety tables or recommendations.
Yamada's Gastroenterology (the most comprehensive reference for GI disorders in pregnancy) lists loperamide as the preferred antidiarrheal in pregnancy and covers bismuth subsalicylate, alosetron, diphenoxylate/atropine, and bile acid sequestrants — but racecadotril is not mentioned in the pregnancy treatment section.
Goodman & Gilman's notes only that racecadotril is "efficacious and safe in children with acute diarrhea" — no pregnancy data are cited.
Clinical Implications
| Parameter | Summary |
|---|
| Mechanism | Peripheral enkephalinase inhibitor — antisecretory, does not affect motility |
| Pregnancy data | Absent from major references — no established human pregnancy safety profile |
| CNS penetration | Thiorphan (active metabolite) does not penetrate the CNS — reduces systemic opioid concern |
| Preferred alternative | Loperamide — the established first-choice antidiarrheal in pregnancy |
| Regulatory status | Not FDA-approved; not in US formulary |
Bottom Line
Racecadotril's peripheral mechanism and lack of CNS effects make it theoretically appealing in pregnancy, but no human pregnancy safety data exist in standard references. Until such data are available:
- Loperamide remains the preferred antidiarrheal agent in pregnancy
- Racecadotril should only be considered if loperamide is contraindicated or unavailable, on a case-by-case risk-benefit basis
- Oral rehydration and dietary modification remain the mandatory first-line approach regardless
— Goodman & Gilman's Pharmacological Basis of Therapeutics; Yamada's Textbook of Gastroenterology, 7th ed.; Goldman-Cecil Medicine